Chemours Co (CC)
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Every figure as a table ›
Revenue Quarterly
0
700M
1.4B
2.1B
Q3 '21: 1.7B
Q4 '21: 1.6B
Q1 '22: 1.8B
Q2 '22: 1.9B
Q3 '22: 1.8B
Q4 '22: 1.3B
Q1 '23: 1.5B
Q2 '23: 1.6B
Q3 '23: 1.5B
Q4 '23: 1.4B
Q1 '24: 1.4B
Q2 '24: 1.6B
Q3 '24: 1.5B
Q4 '24: 1.4B
Q1 '25: 1.4B
Q2 '25: 1.6B
Q3 '25: 1.5B
Q4 '25: 1.3B
Q1 '26: 1.4B
Q2 '26: 1.6B
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Gross Profit Quarterly
0
200M
400M
600M
Q3 '21: 427M
Q4 '21: 393M
Q1 '22: 486M
Q2 '22: 497M
Q3 '22: 432M
Q4 '22: 202M
Q1 '23: 368M
Q2 '23: 410M
Q3 '23: 273M
Q4 '23: 251M
Q1 '24: 284M
Q2 '24: 308M
Q3 '24: 286M
Q4 '24: 265M
Q1 '25: 236M
Q2 '25: 278M
Q3 '25: 233M
Q4 '25: 156M
Q1 '26: 212M
Q2 '26: 286M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income Quarterly
-450M
-300M
-150M
0
150M
300M
450M
Q3 '21: 214M
Q4 '21: 233M
Q1 '22: 234M
Q2 '22: 201M
Q3 '22: 240M
Q4 '22: -97M
Q1 '23: 145M
Q2 '23: -376M
Q3 '23: 12M
Q4 '23: -18M
Q1 '24: 54M
Q2 '24: 60M
Q3 '24: -32M
Q4 '24: -11M
Q1 '25: -5M
Q2 '25: -380M
Q3 '25: 60M
Q4 '25: -47M
Q1 '26: -29M
Q2 '26: -274M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Cost of Revenue Quarterly
0
500M
1B
1.5B
Q3 '21: 1.3B
Q4 '21: 1.2B
Q1 '22: 1.3B
Q2 '22: 1.4B
Q3 '22: 1.3B
Q4 '22: 1.1B
Q1 '23: 1.2B
Q2 '23: 1.2B
Q3 '23: 1.2B
Q4 '23: 1.1B
Q1 '24: 1.1B
Q2 '24: 1.2B
Q3 '24: 1.2B
Q4 '24: 1.1B
Q1 '25: 1.1B
Q2 '25: 1.3B
Q3 '25: 1.3B
Q4 '25: 1.2B
Q1 '26: 1.2B
Q2 '26: 1.3B
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Cash Flow Quarterly
-750M
-500M
-250M
0
250M
500M
750M
Q3 '21: 311M
Q4 '21: 208M
Q1 '22: 2M
Q2 '22: 291M
Q3 '22: 301M
Q4 '22: 161M
Q1 '23: -124M
Q2 '23: 67M
Q3 '23: 131M
Q4 '23: 482M
Q1 '24: -290M
Q2 '24: -620M
Q3 '24: 139M
Q4 '24: 138M
Q1 '25: -112M
Q2 '25: 93M
Q3 '25: 146M
Q4 '25: 137M
Q1 '26: -44M
Q2 '26: 158M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow Quarterly
-750M
-500M
-250M
0
250M
500M
750M
Q3 '21: 244M
Q4 '21: 125M
Q1 '22: -104M
Q2 '22: 229M
Q3 '22: 229M
Q4 '22: 94M
Q1 '23: -215M
Q2 '23: 9M
Q3 '23: 45M
Q4 '23: 347M
Q1 '24: -392M
Q2 '24: -693M
Q3 '24: 63M
Q4 '24: 29M
Q1 '25: -196M
Q2 '25: 50M
Q3 '25: 105M
Q4 '25: 92M
Q1 '26: -93M
Q2 '26: 114M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
60M
120M
180M
Q1 '20: 165.3M
Q2 '20: 165.4M
Q3 '20: 166.6M
Q1 '21: 169.1M
Q2 '21: 170.2M
Q3 '21: 169M
Q1 '22: 163.6M
Q2 '22: 159.7M
Q3 '22: 157.9M
Q1 '23: 151.2M
Q2 '23: 149.1M
Q3 '23: 150.2M
Q1 '24: 150.1M
Q2 '24: 150.1M
Q3 '24: 149.7M
Q1 '25: 149.9M
Q2 '25: 150.2M
Q3 '25: 150.8M
Q1 '26: 150.8M
Q2 '26: 151.2M
Q2 '20
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-4.00
-2.00
0.00
2.00
4.00
6.00
Q3 '21: 2.34
Q4 '21: 3.62
Q1 '22: 4.48
Q2 '22: 5.35
Q3 '22: 5.60
Q4 '22: 3.56
Q1 '23: 3.09
Q2 '23: -0.69
Q3 '23: -2.13
Q4 '23: -1.60
Q1 '24: -2.20
Q2 '24: 0.71
Q3 '24: 0.41
Q4 '24: 0.45
Q1 '25: 0.06
Q2 '25: -2.86
Q3 '25: -2.24
Q4 '25: -2.47
Q1 '26: -2.63
Q2 '26: -1.91
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.
Not drawn for CC:
Operating Income . Nothing in this filer's XBRL supports
it for the periods asked for. That is a gap in
the filing, not a zero, and drawing a flat line would be an invention.